Table 4. In-hospital and 30-day period clinical outcome data of the study population .

	Patients (N = 94)	Angiographic reperfusion		p value	Electrocardiographic reperfusion		p value
		No reflow (n = 10)	Good reflow (n = 84)		No-reflow (n = 23)	Good reflow (n = 71)
Inhospital
Death, n (%)	10 (10)	4 (40)	6 (7)	0.01	7 (30)	3 (4)	0.002
Re-MI, n (%)	16 (17)	4 (40)	12 (14)	0.06	8 (35)	8 (11)	0.02
Stent thrombosis, n (%)	16 (17)	4 (40)	12 (14)	0.06	8 (35)	8 (11)	0.02
30 days
Hospitalization, n (%)	14 (15)	2 (20)	12 (14)	0.6	2 (9)	12 (17)	0.5
Death, n (%)	1 (1)	1 (10)	0 (0)	0.1	1 (4)	0 (0)	0.2
Re-MI, n (%)	7 (7)	2 (20)	5 (6)	0.2	3 (13)	9 (12)	0.9
Stent thrombosis, n (%)	7 (7)	2 (20)	5 (6)	0.2	2 (9)	5 (7)	0.9
Composite end point, n(%)	12 (13)	2 (20)	10 (12)	0.6	3 (13)	9 (12)	0.9

Re-MI, recurrent miyocardial infarction; ST, stent thrombosis.